Medical/Pharmaceuticals
B dot Medical Developing Ultra-compact Proton Cancer Therapy System That Can Replace X-ray Cancer Therapy System
TOKYO, May 24, 2019 /PRNewswire/ -- B dot Medical Inc. announced on May 24 that the company has initiated the development of an ultra-compact proton cancer therapy system that can replace the commonly used x-ray cancer therapy system (LINAC). More than 180,000 patients have been treated in proto...
2019-05-24 14:00
2525
Ovid Therapeutics to Present at the 12th International Epilepsy Colloquium
First scientific presentation of OV-935 (TAK-935) safety and tolerability data in developmental and epileptic encephalopathies from the Phase1b/2a clinical trial Study met primary safety and tolerability endpoints and showed initial evidence of potential efficacy in seizure reduction Data encou...
2019-05-24 05:04
7438
APRINOIA Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson's Research
TAIPEI, , May 23, 2019 /PRNewswire/ -- APRINOIA Therapeutics, a clinical-stage biotechnology company with a pipeline of therapeutics and imaging diagnostics for neurodegenerative diseases, announces today that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson'...
2019-05-23 20:00
2938
MGI introduces total solution for single cell RNA sequencing using MGISEQ-2000 sequencing platform compatible with 10x Genomics
TOKYO, May 23, 2019 /PRNewswire/ -- MGI
2019-05-23 19:02
2916
Phebra establishes new subsidiary in Canada and announces marketing approval for its IV Arsenic Trioxide Solution
SYDNEY, May 23, 2019 /PRNewswire/ -- Australian pharmaceutical firm Phebra (the 'Company') has continued its international business expansion with the opening of its subsidiary inMontreal, Canada. The new entity, Phebra Canada, will be headed byTony Romagnino, Vice President of Phebra's current N...
2019-05-23 17:00
1785
Tencent Miying Launches AI-supported Auxiliary Diagnostic System
KUNMING, China, May 22, 2019 /PRNewswire/ -- Tencent today announces the launch of an AI-supported auxiliary diagnostic system for conducting digital colposcopy at the Global Digital Ecosystem Summit being held inKunming, China. This latest technology can rapidly identify the cervical transforma...
2019-05-23 04:47
7537
China SXT Pharmaceuticals, Inc. Being Admitted to Hi-tech Zone of Huangshan City in Anhui Province
TAIZHOU, China, May 22, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces ("TCMPs"), announced today the laun...
2019-05-22 23:20
6988
Vitaeris Announces Multiple Scientific Presentations Involving Clazakizumab at the 2019 American Transplant Congress
- Anti-Interleukin 6 Monoclonal Antibody for Antibody-Mediated Kidney Transplant Rejection - 8 Oral & Poster Presentations VANCOUVER, British Columbia, May 22, 2019 /PRNewswire/ -- Vitaeris Inc. (Vitaeris) today announced that eight abstracts involving or related to clazakizumab, Vitaeris' pro...
2019-05-22 20:30
1787
Scientists Identify New Therapeutic Target for Fatty Liver Disease
* Preclinical study highlights a novel therapy for the treatment of fatty liver disease, which affects up to 25% of the global population * Inhibiting interleukin 11 (IL11) signalling addresses multiple aspects of non-alcoholic steatohepatitis (NASH), including hepatic inflammation and fibros...
2019-05-22 18:24
1958
FDA Approves SORILUX(R) for Adolescent Plaque Psoriasis
ADELAIDE, Australia, May 22, 2019 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has approved SORILUX® (calcipotriene) Foam, 0.005% in adolescents. SORILUX is now approved for treating plaque psoriasis of the scalp and b...
2019-05-22 18:00
6567
Saluda Medical Announces New 3-Month, 12-Month and 18-Month Data Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System to be Presented at 14th INS World Congress
11 Presentations – Including 4 Plenary Presentations – to Feature the Evoke System ARTARMON, Australia, May 20, 2019 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced that new data from multiple studies evaluating the company's Evoke® ECAP-Controlled, Closed-Loop Spin...
2019-05-20 16:00
1738
Bridge Biotherapeutics Announces Data Presentation from First-in-Human Study of BBT-877 for Idiopathic Pulmonary Fibrosis
SEONGNAM, South Korea and DALLAS, May 20, 2019 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical-stage biotech company developing novel therapeutics for areas with high unmet medical needs, announced that the company presented interim data from a Phase I clinical study on BBT-877, a drug c...
2019-05-20 08:38
1810
ChemPartner and Berkeley Lights Take Next Step in B Cell Antibody Discovery Collaboration
SHANGHAI and SOUTH SAN FRANCISCO, Calif., May 16, 2019 /PRNewswire/ -- Shanghai
ChemPartner
2019-05-16 23:00
1774
Hebron Technology Co., Ltd. Reports Fiscal Year 2018 Financial Results
WENZHOU, China, May 15, 2019 /PRNewswire/ -- Hebron Technology Co., Ltd. (" Hebron" or the "Company") (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in the pharmaceutical, biological, food and beverage, and other clean industries, today announced its f...
2019-05-16 05:00
11011
NeuClone to Initiate Phase I Clinical Trial of Stelara (Ustekinumab) Biosimilar, the Second Biosimilar from the 10-product Portfolio with Serum Institute
SYDNEY, May 15, 2019 /PRNewswire/ -- NeuClone Pharmaceuticals Ltd. (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, today announced it will initiate the Phase I clinical trial of its Stelara® (ustekinumab) biosimilar in t...
2019-05-15 20:13
1896
China Pharma Holdings, Inc. Reports First Quarter 2019 Financial Results
HAIKOU, China, May 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter ...
2019-05-15 18:00
8356
Ortho Clinical Diagnostics to Host 4th Annual Hospital C-Suite Summit in Singapore
2-Day Summit Will Bring Together Top Hospital Executives and Focus on Patient Safety and Service Excellence RARITAN, New Jersey and SINGAPORE, May 14, 2019 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, in collaboration withSingapore Management University, w...
2019-05-14 07:00
2684
AirXpanders® Announces Special 510(k) Submission to the US FDA for a Smooth Shell Version of the AeroForm® Tissue Expander System
SAN JOSE, California, May 13, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the company has submitted a Special 510(k) pre-market notification to t...
2019-05-14 04:09
1108
China Biologic Reports Financial Results for the First Quarter of 2019
--1Q19 Total Sales Up 15.4% YoY in USD terms, or 22.3% YoY in RMB terms; Net Income Up 19.3% YoY to $37.7 Million; Non-GAAP Adjusted Net Income Up 14.3% YoY in RMB terms -- BEIJING, May 10, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"...
2019-05-11 04:30
9546
OliX Pharmaceuticals Expands Ocular Disease Pipeline; Adds OLX304A for the Treatment of Retinitis Pigmentosa
SUWON, South Korea, May 9, 2019 /PRNewswire/ -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics,announced today an expansion of its ocular disease pipeline. Specifically, the company announced that OLX304A has been added to develop an RNAi therapeutic with...
2019-05-10 09:24
1551
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 276 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 274 media titles]
2024-04-24 17:09
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
7855
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
6951
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
2024-04-23 15:43
5070